Typicality: | 0.428 |
Saliency: | 0.291 |
during lv remodeling | 3 | temporal |
during colorectal cancer progression | 3 | temporal |
during lfs patient osteoblast differentiation | 2 | temporal |
gene → be → dysregulated | 18 |
gene → become → dysregulated | 4 |
negative | neutral | positive |
0.400 | 0.568 | 0.032 |
Raw frequency | 22 |
Normalized frequency | 0.291 |
Modifier score | 0.667 |
Perplexity | 82.902 |